Citations

Clear

4847 citation(s) found for "Yu, Eric".

"Neutral Needle Please!" - How Empowering Endoscopy Staff Decreased Our EBUS Scope Damages by $72,730 a Year
Crossan, J., Kalluri, S., Reister-Morris, P., Sangwan, Y., Edell, Eric S.

Mayo Clinic

A35. INTERVENTIONAL PULMONOLOGY | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A1394-A1394

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1394 Get It

Bronchoscopic Lung Biopsy for Diffuse Parenchymal Lung Disease: Comparison of Forceps with Cryobiopsy
Edell, Eric S. , Moua, Teng , Roden, Anja C. , Yi, Eunhee S. , Decker, Paul A. , Koslow, Matthew , Decker, Paul A. , Ryu, Jay H.

Mayo Clinic

C22. ILD: DIAGNOSIS | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A4317-A4317

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4317 Get It

Serial Bronchoscopic Cryobiopsies Allowing Extubation in a Patient with Central Airway Obstruction from Peripheral T-Cell Lymphoma
Kelly, Brent , Romero-Legro, Ivan, Edell, Eric S. , Kelly, B.

Mayo Clinic

B41. INTERVENTIONAL PULMONOLOGY CASE REPORTS I | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A3170-A3170

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3170 Get It

Role of Suppression of Tumorigenecity (ST2) in Pulmonary Vascular Complications of Liver Disease
Krowka, Michael J. , Forde, Kimberly A. , Patel, M., Lin, Grace , Oh, Jae K. , Bull, T.M., Bartolome, Sonja, Mottram, Carl, Scanlon, Paul D., Hemnes, A., Fallon, Michael B. , Minhas, Jasleen , Heresi, Gustavo A. , Roberts, Kari E. , DuBrock, Hilary M. , Krok, Karen , Austin, Eric , Kawut, Steven M. , Al‐Naamani, Nadine

Mayo Clinic

D56. X MARKS THE SPOT: NEW BIOMARKERS IN PAH | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A6821-A6821

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6821 Get It

Techniques and Tips for Freehand Placement of C7 Pedicle Screws With Respect to Cervicothoracic Constructs: 2-Dimensional Operative Video
Clifton, William , Edwards, Steve, Louie, Christopher, Dove, Conrad, Damon, Aaron , Nottmeier, Eric W. , Pichelmann, Mark A., Nottmeier, Eric, Pichelmann, Mark, Clifton, William E

Mayo Clinic

Operative Neurosurgery | August 23, 2019 | Volume: 18 | Issue: 6 | Pages: E234-E234

10.1093/ons/opz235 | PMID 31504858 Get It

Abstract We present a surgical video highlighting the technical pearls for C7 pedicle screw placement with respect to cervicothoracic constructs. Pedicle screw placement into C7 has been shown to enhance the biomechanical stability of both cervical and cervicothoracic constructs and is safe for patient related outcomes. 1 , 2 Rod placement across the cervicothoracic junction is known to be difficult because of the variable starting point of the C7 pedicle screw, which may cause misalignment of the polyaxial heads with respect to the C7 and C6 screw heads. Using our step-wise method of anatomic screw placement, this potential pitfall is minimized. The T1 pedicle screw is placed first. The C6 lateral mass screw starting point is displaced slightly superiorly from the midpoint of the lateral mass in order to make room for the polyaxial head of the C7 pedicle screw. A small laminotomy is performed in order to find the medial border of the C7 pedicle. Palpation of the medial border allows for an approximation of the pedicle limits. The cranial-caudal angle of drilling is perpendicular to the C7 superior facet, and the medial-lateral trajectory typically falls between 15 and 20 degrees medial. Once the pedicle is cannulated, a ball-tipped probe is used to confirm intraosseous position. A rod is cut and contoured to the appropriate length of the construct. The C7 pedicle screw should capture the rod easily with slight displacement of the polyaxial head. Postinstrumentation anteroposterior and lateral fluoroscopy are performed to confirm good position of the lateral mass and pedicle screws. Patient consent was not required for this cadaveric surgical video.
Closing the Brief Case: Bartonella henselae Endocarditis—a Case of Delayed Diagnosis
Rodino, Kyle G. , Saleh, Omar Abu , Theel, Elitza S. , Stone, Eric, Abu Saleh, Omar , Stone, Eric

Mayo Clinic

Journal of Clinical Microbiology | August 23, 2019 | Volume: 57 | Issue: 9 | Pages: No page available

10.1128/jcm.00123-19 | PMID 31451568 Get It

The Brief Case: Bartonella henselae Endocarditis—a Case of Delayed Diagnosis
Rodino, Kyle G. , Saleh, Omar Abu , Theel, Elitza S. , Stone, Eric, Stone, Eric

Mayo Clinic

Journal of Clinical Microbiology | August 23, 2019 | Volume: 57 | Issue: 9 | Pages: No page available

10.1128/jcm.00114-19 | PMID 31451567 Get It

Genome‐Wide Meta‐Analysis of Blood Pressure Response to β 1 ‐Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies)
Hiltunen, Timo P. , McDonough, Caitrin W. , Rouby, Nihal El , Salvi, Erika , Wang, Zhiying , Garofalidou, Tatiana, Fyhrquist, F, Kontula, Kimmo , Glorioso, Valeria, Zaninello, Roberta, Glorioso, Nicola, Pepine, Carl J. , Munroe, Patricia B. , Turner, Stephan T., Chapman, Arlene B. , Boerwinkle, Eric , Johnson, Julie A. , Munroe, Patricia B , Singh, Sonal , Warren, Helen R. , Chapman, Arlene B. , Gong, Yan , Cooper‐DeHoff, Rhonda M.

Mayo Clinic

Journal of the American Heart Association | August 19, 2019 | Volume: 8 | Issue: 16 | Pages: No page available

10.1161/jaha.119.013115 | PMID 31423876 Get It

Background There exists a wide interindividual variability in blood pressure ( BP ) response to β 1 ‐blockers. To identify the genetic determinants of this variability, we performed a pharmacogenomic genome‐wide meta‐analysis of genetic variants influencing β 1 ‐blocker BP response. Methods and Results Genome‐wide association analysis for systolic BP and diastolic BP response to β 1 ‐blockers from 5 randomized clinical trials consisting of 1254 patients with hypertension of European ancestry were combined in meta‐analysis and single nucleotide polymorphisms (SNPs) with P <10 −4 were tested for replication in 2 independent randomized clinical trials of β 1 ‐blocker–treated patients of European ancestry (n=1552). Regions harboring the replicated SNP s were validated in a β 1 ‐blocker–treated black cohort from 2 randomized clinical trials (n=315). A missense SNP rs28404156 in BST 1 was associated with systolic BP response to β 1 ‐blockers in the discovery meta‐analysis ( P =9.33×10 −5 , β=−3.21 mm Hg) and replicated at Bonferroni significance ( P =1.85×10 −4 , β=−4.86 mm Hg) in the replication meta‐analysis with combined meta‐analysis approaching genome‐wide significance ( P =2.18×10 −7 ). This SNP in BST 1 is in linkage disequilibrium with several SNP s with putative regulatory functions in nearby genes, including CD 38 , FBXL 5 , and FGFBP 1 , all of which have been implicated in BP regulation. SNP s in this genetic region were also associated with BP response in the black cohort. Conclusions Data from randomized clinical trials of 8 European ancestry and 2 black cohorts support the assumption that BST 1 containing locus on chromosome 4 is associated with β 1 ‐blocker BP response. Given the previous associations of this region with BP , this is a strong candidate region for future functional studies and potential use in precision medicine approaches for BP management and risk prediction.
Sex Differences in the Use of Statins in Community Practice
Wang, Tracy Y., Xiang, Qun, Goldberg, Anne C. , Robinson, Jennifer G. , Roger, Véronique L. , Louie, Michael J. , Koren, Andrew , Li, Zhuokai , Nanna, Michael G. , Virani, Salim S. , Wilson, Peter W.F. , Peterson, Eric D. , Návar, Ann Marie

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | August 16, 2019 | Volume: 12 | Issue: 8 | Pages: No page available

10.1161/circoutcomes.118.005562 | PMID 31416347 Get It

Background: Female patients have historically received less aggressive lipid management than male patients. Contemporary care patterns and the potential causes for these differences are unknown. Methods and Results: Examining the Patient and Provider Assessment of Lipid Management Registry—a nationwide registry of outpatients with or at risk for atherosclerotic cardiovascular disease—we compared the use of statin therapy, guideline-recommended statin dosing, and reasons for undertreatment. We specifically analyzed sex differences in statin treatment and guideline-recommended statin dosing using multivariable logistic regression. Among 5693 participants (43% women) eligible for 2013 American College of Cardiology/American Heart Association Cholesterol Guideline–recommended statin treatment, women were less likely than men to be prescribed any statin therapy (67.0% versus 78.4%; P <0.001) or to receive a statin at the guideline-recommended intensity (36.7% versus 45.2%; P <0.001). Women were more likely to report having previously never been offered statin therapy (18.6% versus 13.5%; P <0.001), declined statin therapy (3.6% versus 2.0%; P <0.001), or discontinued their statin (10.9% versus 6.1%; P <0.001). Women were also less likely than men to believe statins were safe (47.9% versus 55.2%; P <0.001) or effective (68.0% versus 73.2%; P <0.001) and more likely to report discontinuing their statin because of a side effect (7.9% versus 3.6%; P <0.001). Sex differences in both overall and guideline-recommended intensity statin use persisted after adjustment for demographics, socioeconomic factors, clinical characteristics, patient beliefs, and provider characteristics (adjusted odds ratio, 0.70; 95% CI, 0.61–0.81; P <0.001; and odds ratio, 0.82; 95% CI, 0.73–0.92; P <0.01, respectively). Sex differences were consistent across primary and secondary prevention indications for statin treatment. Conclusions: Women eligible for statin therapy were less likely than men to be treated with any statin or guideline-recommended statin intensity. A combination of women being offered statin therapy less frequently, while declining and discontinuing treatment more frequently, accounted for these sex differences in statin use.